ShareValue.ai

ShareValue scores for ANIP: Valuation 61, Quality 65, Growth 51, Health 52.

ANIP
NASDAQ

ANI Pharmaceuticals Inc

$84.50(+1.46%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 17%
Valuation
61
Fair Value
Price vs Value
Quality
65
Moderate
Business Strength
Growth
51
Moderate
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
46
Neutral
Price Trend

Company Details

About

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026